The CHOICE Institute will be well-represented at the 2026 ISPOR Annual Conference — the premier gathering of the global health economics and outcomes research (HEOR) community — taking place May 17–20 in Philadelphia. Faculty, fellows, and students will present 23 research posters and participate in several featured sessions throughout the week.
Download our conference guide to explore the full lineup of CHOICE presentations and activities.`
Highlights:
Sunday, May 17
- Professor Sean D. Sullivan will receive the Avedis Donabedian Lifetime Achievement Award at the ISPOR Awards Ceremony (6:00–8:00 PM, Juniper Ballroom, Notary Hotel Philadelphia)
- CHOICE PhD program alumnus Dr. Boshen Jiao (’22) will receive the Bernie O’Brien New Investigator Award at the same ceremony
Monday, May 18
- Professor Sean D. Sullivan will present in a breakout session on Value-Based Pricing for CMS Drug Price Negotiation: Mission Impossible?
Tuesday, May 19
- Beth Devine, CHOICE Professor Emerita and ISPOR President, will deliver the Presidential Address
- Scott Ramsey, CHOICE Adjunct Professor, will moderate the plenary session, The True Cost of Cancer: Aligning Innovation, Access, and Affordability
- Professor Emeritus Lou Garrison will moderate a breakout session on Including Equity in Health Technology Assessment
- Professor & Stergachis Family Endowed Director Anirban Basu will present in a breakout session on new approaches to dynamic efficiency and balancing access and innovation in pharmaceutical markets
Wednesday, May 20
- PhD candidate YunJoo Karris Jeon will present her dissertation work, Projected Medicare Drug Price Negotiation Savings in 2027, in a podium session
- Professor Emerita Beth Devine will moderate a spotlight session on transparent, validated LLM workflows for accelerating global HTA submissions
- Affiliate Professor John Watkins will speak in a session on From Debate to Dialogue: Building Consensus on Prior Authorization Reform
- Affiliate Professors Lotte Steuten and Jens Grueger will speak in the closing plenary, Innovation Under Pressure: How Will US Drug Policy Reshape Innovation, Evidence, and Access Globally?